Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedAug 02, 2026
DataAggregated Company Financials
Companies6
- 7D6.6%
- 3M-16.1%
- 1Y-24.5%
- YTDn/a
The Drug Retail industry is up 6.6% in the last week, with JD Health International up 6.5%. In the same time, Lung Fung Group Holdings was down 9.6%. In contrast, the industry has lost 24% in the last 12 months. Looking forward, earnings are forecast to grow by 15% annually.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 02 Aug 2026 | HK$203.2b | HK$143.6b | HK$8.7b | 31.8x | 23.2x | 1.4x |
| Tue, 30 Jun 2026 | HK$178.2b | HK$142.7b | HK$8.7b | 29x | 20.5x | 1.2x |
| Thu, 28 May 2026 | HK$210.6b | HK$142.8b | HK$8.7b | 35.3x | 24.2x | 1.5x |
| Sat, 25 Apr 2026 | HK$249.7b | HK$140.3b | HK$8.6b | 44.3x | 29x | 1.8x |
| Mon, 23 Mar 2026 | HK$266.0b | HK$140.3b | HK$7.8b | 87.9x | 34.3x | 1.9x |
| Wed, 18 Feb 2026 | HK$331.0b | HK$129.4b | HK$6.9b | 45.7x | 47.8x | 2.6x |
| Fri, 16 Jan 2026 | HK$379.9b | HK$128.0b | HK$6.9b | 53.6x | 55.4x | 3x |
| Sun, 14 Dec 2025 | HK$313.8b | HK$126.2b | HK$6.8b | 40.5x | 46.4x | 2.5x |
| Tue, 11 Nov 2025 | HK$327.0b | HK$122.2b | HK$6.1b | 59.8x | 53.2x | 2.7x |
| Thu, 09 Oct 2025 | HK$368.6b | HK$122.4b | HK$6.2b | 68.2x | 59.9x | 3x |
| Sat, 06 Sep 2025 | HK$368.4b | HK$122.4b | HK$6.2b | 66.8x | 59.9x | 3x |
| Mon, 04 Aug 2025 | HK$269.7b | HK$114.8b | HK$4.5b | 49.8x | 60.1x | 2.3x |
| Wed, 02 Jul 2025 | HK$242.0b | HK$115.6b | HK$4.5b | 48.7x | 53.6x | 2.1x |
| Fri, 30 May 2025 | HK$232.3b | HK$115.1b | HK$4.5b | 48.4x | 51.7x | 2x |
| Sun, 27 Apr 2025 | HK$214.7b | HK$109.9b | HK$4.1b | 58.2x | 51.8x | 2x |
| Tue, 25 Mar 2025 | HK$216.2b | HK$110.7b | HK$4.2b | 63.1x | 51.8x | 2x |
| Thu, 20 Feb 2025 | HK$230.5b | HK$103.8b | HK$3.6b | 56.7x | 64.1x | 2.2x |
| Sat, 18 Jan 2025 | HK$154.8b | HK$103.2b | HK$3.6b | 37x | 43.3x | 1.5x |
| Mon, 16 Dec 2024 | HK$166.6b | HK$103.9b | HK$3.6b | 39.6x | 46.3x | 1.6x |
| Wed, 13 Nov 2024 | HK$173.8b | HK$103.1b | HK$3.3b | 50.6x | 53.2x | 1.7x |
| Fri, 11 Oct 2024 | HK$181.8b | HK$105.3b | HK$3.3b | 52.2x | 54.4x | 1.7x |
| Sun, 08 Sep 2024 | HK$137.2b | HK$105.4b | HK$3.3b | 37x | 41x | 1.3x |
| Tue, 06 Aug 2024 | HK$138.1b | HK$103.5b | HK$2.4b | 41.3x | 57x | 1.3x |
| Thu, 04 Jul 2024 | HK$139.4b | HK$101.8b | HK$2.4b | 42.1x | 58.4x | 1.4x |
| Sat, 01 Jun 2024 | HK$155.3b | HK$102.4b | HK$2.4b | 45.7x | 64.8x | 1.5x |
| Mon, 29 Apr 2024 | HK$150.8b | HK$103.7b | HK$2.3b | 45.2x | 64.8x | 1.5x |
| Wed, 27 Mar 2024 | HK$162.5b | HK$103.7b | HK$13.7m | 48.9x | 11823.8x | 1.6x |
| Fri, 23 Feb 2024 | HK$176.6b | HK$105.1b | -HK$1,456,594,231.42 | 58.4x | -121.3x | 1.7x |
| Sun, 21 Jan 2024 | HK$165.0b | HK$105.6b | -HK$1,470,585,085.00 | 52.8x | -112.2x | 1.6x |
| Tue, 19 Dec 2023 | HK$207.8b | HK$105.6b | -HK$1,463,640,246.00 | 64.9x | -142x | 2x |
| Thu, 16 Nov 2023 | HK$225.4b | HK$102.6b | -HK$1,749,922,719.00 | 93.2x | -128.8x | 2.2x |
| Sat, 14 Oct 2023 | HK$224.7b | HK$102.3b | -HK$1,674,861,447.00 | 104.7x | -134.2x | 2.2x |
| Mon, 11 Sep 2023 | HK$227.3b | HK$102.0b | -HK$1,669,943,661.00 | 84.1x | -136.1x | 2.2x |
| Wed, 09 Aug 2023 | HK$277.9b | HK$95.7b | -HK$4,153,332,356.00 | 128.8x | -66.9x | 2.9x |
Price to Earnings Ratio
-66.9x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 23.2x which is lower than its 3-year average PE of 100x.
- The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 14% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | 2.63% | |
| Consumer Staples | 5.91% | |
| Food and Staples Retail | 6.53% | |
| Drug Retail | 6.58% | |
| Food Retail | 8.09% | |
| Food Distributors | -1.42% | |
| Big Box Super Stores | -1.82% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6618 JD Health International | HK$39.40 | 6.5% +HK$7.7b | -19.2% | PE20.1x | |
| 241 Alibaba Health Information Technology | HK$3.59 | 7.5% +HK$4.0b | -25.5% | PE25.8x | |
| 1833 Ping An Healthcare and Technology | HK$7.82 | 6.0% +HK$935.7m | -34.8% | PE37.7x | |
| 314 Sipai Health Technology | HK$1.32 | 1.5% +HK$14.6m | -78.0% | PS0.4x |